141 related articles for article (PubMed ID: 38484584)
21. The impact of visceral pleural invasion in node-negative non-small cell lung cancer: a systematic review and meta-analysis.
Jiang L; Liang W; Shen J; Chen X; Shi X; He J; Yang C; He J
Chest; 2015 Oct; 148(4):903-911. PubMed ID: 25675151
[TBL] [Abstract][Full Text] [Related]
22. Level of pleural invasion effects on prognosis in lung cancer.
Tanju S; Erus S; Selçukbiricik F; İliaz S; Kapdağlı M; Bulutay P; Sevinç TE; Mandel NM; Dilege Ş
Tumori; 2019 Apr; 105(2):155-160. PubMed ID: 30165792
[TBL] [Abstract][Full Text] [Related]
23. Impact of skip mediastinal lymph node metastasis on outcomes after resection for primary lung cancer.
Taylor M; Soliman N; Paoletti E; King M; Crosbie PAJ; Granato F
Lung Cancer; 2023 Oct; 184():107341. PubMed ID: 37573704
[TBL] [Abstract][Full Text] [Related]
24. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
[TBL] [Abstract][Full Text] [Related]
26. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
Moon Y; Lee KY; Park JK
World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
[TBL] [Abstract][Full Text] [Related]
27. Sialyl Lewis X as a predictor of skip N2 metastasis in clinical stage IA non-small cell lung cancer.
Komatsu H; Mizuguchi S; Izumi N; Chung K; Hanada S; Inoue H; Suehiro S; Nishiyama N
World J Surg Oncol; 2013 Dec; 11():309. PubMed ID: 24313932
[TBL] [Abstract][Full Text] [Related]
28. Recurrence Pattern of Pathologic Stage I Lung Adenocarcinoma With Visceral Pleural Invasion.
Jiwangga D; Cho S; Kim K; Jheon S
Ann Thorac Surg; 2017 Apr; 103(4):1126-1131. PubMed ID: 27993377
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of visceral pleural invasion in pure-solid and part-solid lung cancer patients.
Okada S; Hattori A; Matsunaga T; Takamochi K; Oh S; Inoue M; Suzuki K
Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):303-310. PubMed ID: 32918675
[TBL] [Abstract][Full Text] [Related]
30. Role of Skip Mediastinal Lymph Node Metastasis for Patients With Resectable Non-small-cell Lung Cancer: A Propensity Score Matching Analysis.
Wang L; Zhan C; Gu J; Xi J; Lin Z; Xue L; Ge D; Wang Q
Clin Lung Cancer; 2019 May; 20(3):e346-e355. PubMed ID: 30665872
[TBL] [Abstract][Full Text] [Related]
31. Risk Factors for Occult Lymph Node Metastasis in Peripheral Non-Small Cell Lung Cancer with Invasive Component Size 3 cm or Less.
Moon Y; Choi SY; Park JK; Lee KY
World J Surg; 2020 May; 44(5):1658-1665. PubMed ID: 31912252
[TBL] [Abstract][Full Text] [Related]
32. Correlation between pleural tags on CT and visceral pleural invasion of peripheral lung cancer that does not appear touching the pleural surface.
Onoda H; Higashi M; Murakami T; Tao H; Yokoyama S; Kunihiro Y; Kawano R; Tanabe M; Tanaka N; Matsumoto T
Eur Radiol; 2021 Dec; 31(12):9022-9029. PubMed ID: 34019129
[TBL] [Abstract][Full Text] [Related]
33. Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma.
Nitadori JI; Colovos C; Kadota K; Sima CS; Sarkaria IS; Rizk NP; Rusch VW; Travis WD; Adusumilli PS
Chest; 2013 Nov; 144(5):1622-1631. PubMed ID: 23807749
[TBL] [Abstract][Full Text] [Related]
34. Clinical Significance of Dual-Block Elastic Stain Evaluating Visceral Pleural Invasion in Peripheral Non-Small Cell Lung Cancer.
Li S; Huang Y; Zhang L; Dong Z; Wu W; Zhang W; Wu C; Hou L
Int J Surg Pathol; 2023 Apr; 31(2):175-183. PubMed ID: 35758404
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival.
Wightman SC; Lee JY; Ding L; Atay SM; Shemanski KA; McFadden PM; David EA; Kim AW
Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35325098
[TBL] [Abstract][Full Text] [Related]
36. Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size.
David E; Thall PF; Kalhor N; Hofstetter WL; Rice DC; Roth JA; Swisher SG; Walsh GL; Vaporciyan AA; Wei C; Mehran RJ
Ann Thorac Surg; 2013 Jun; 95(6):1872-7; discussion 1877. PubMed ID: 23643547
[TBL] [Abstract][Full Text] [Related]
37. The value of CT radiomics features to predict visceral pleural invasion in ≤3 cm peripheral type early non-small cell lung cancer.
Wei SH; Zhang JM; Shi B; Gao F; Zhang ZX; Qian LT
J Xray Sci Technol; 2022; 30(6):1115-1126. PubMed ID: 35938237
[TBL] [Abstract][Full Text] [Related]
38. Prognostic impact of uncertain parietal pleural invasion at adhesion sites in non-small cell lung cancer patients.
Mikubo M; Nakashima H; Naito M; Matsui Y; Shiomi K; Jiang SX; Satoh Y
Lung Cancer; 2017 Jun; 108():103-108. PubMed ID: 28625620
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of the extent of visceral pleural invasion in completely resected node-negative non-small cell lung cancer.
Hung JJ; Jeng WJ; Hsu WH; Chou TY; Lin SF; Wu YC
Chest; 2012 Jul; 142(1):141-150. PubMed ID: 22241763
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]